FREE SHIPPING ON ORDERS OVER €49.90

Ciliacell Nasal Spray Children 15 ml

€17,67 €20,13
Tax included, shipping and discounts calculated at checkout.
Nessuno  |  SKU: 951801416  |  Barcode: 8054794360088



Shipping Costs and Times

  • Order fulfilled in 24h
  • Italy, including islands, Free from €49.90
  • Orders under €49.90: €4.99
  • Europe starting from €11

Read the full policy

Payments

Payment information is processed securely. We do not store credit card information or have access to your credit card information.

Returns and Refunds

You can return and receive a refund for the item within 30 days. See full policy here.

5.0 kg
Assistenza Clienti BFarma +39 347 093 4913

Do you need help?

Our customer service is here to help you!

  • Contact us by phone, email or WhatsApp, from Monday to Friday, from 9:00 to 20:00 .
  • For common questions, such as tracking your order or checking its fulfillment status, you can count on our artificial intelligence , available 24/7 .

We are always at your side to offer you fast and effective support!

Description

CILIACELL NASAL SPRAY CHILDREN 15 ML



CILIACELL NASAL SPRAY CHILDREN

Description
Nasal spray indicated for purulent infectious rhinosinusitis (acute and chronic) to promote the evacuation of mucopurulent secretions from the nasosinusal district and Eustachian tubes, decongest the nasosinusal mucosa, and reactivate mucociliary clearance. It is useful in the treatment of purulent infectious rhinosinusitis and/or effusive otitis media when thick mucus (yellow, greenish, or white) is observed draining from the nose or throat, and/or craniofacial pain (corresponding to one or more paranasal sinuses), and/or hyposmia (reduced sense of smell), in association with one or more of the following symptoms:
- Nasosinusal congestion (especially if unilateral);
- Loss of smell (anosmia);
- Reduced hearing (hypoacusis);
- Nosebleed.
The solution containing Cucurbitacins B-D4-E acts on the epithelial surface of the mucosa, causing electrolytic and osmotic changes that promote:
- The expulsion of mucopurulent secretions;
- The restoration of ciliary motility;
- The reduction of mucosal edema;
- The restoration of paranasal sinus pneumatization (air pressure in the paranasal sinuses).
Furthermore, Cucurbitacins B-D-I-E produce a surfactant effect on mucopurulent secretions, promoting their dilution and fluidification.

Instructions for use
For children (6-12 years)
Nasal Spray: 1 or 2 sprays per nostril, once or twice a day (morning and evening), for a cycle of 7 consecutive days. The 7-day treatment can be repeated after a 6-7 day treatment-free interval, depending on the clinical response and symptoms.
The dosage should be adjusted based on product tolerability, symptom severity, and the amount of mucopurulent secretions present in the nasosinusal district and/or Eustachian tubes.
The duration of treatment can be adjusted based on the clinical response and symptoms; however, the minimum treatment duration is seven days: shorter treatments do not guarantee a tangible effect.
For chronic rhinosinusitis (even latent) or post-surgery, at least two cycles as indicated above are recommended, always interspersed with at least 6-7 days without treatment.
For nasal spray (children and adults)
1) Blow your nose to remove mucus or debris to allow the product to effectively reach the nasal areas.
2) Remove the dispenser safety clip and protective cap.
3) Prime the pump by pressing 2-3 times until a regular spray is obtained.
4) Gently insert the dispenser into one nostril, keeping your head upright and slightly tilted forward.
5) Press the spray once while inhaling slowly through your nose.
6) Repeat in the other nostril following the same procedure.
Do not exhale or blow your nose immediately after spraying to avoid dispersing the product (wait 10-15 minutes). Use in children must be supervised or assisted by an adult.

Components
Functional substances: cucurbitacins B-D-I-E extracted from Ecballium elaterium. The quantity present in each formulation is indicated on the individual product bottles.
Excipients: purified water fu, ethyl alcohol, mint aroma, eucalyptol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, polysorbate 80, sodium chloride, monosodium phosphate dihydrate (or citric acid monohydrate), disodium phosphate dodecahydrate (or sodium citrate dihydrate).

Warnings
- All administration operations must be performed gently, avoiding inserting the dispenser tip too deeply into the nostrils and maintaining an upright position during use.
- Close the bottle after each application.
- Store the product away from light and direct heat sources.
- Do not use the product for more than 14 consecutive days without consulting a doctor.
- For individuals with nasal vascular fragility, vasomotor rhinitis (allergic or non-allergic cell-mediated), or in the presence of chronic inflammation or post-surgery, it is recommended to start with only one spray per nostril per day. If well tolerated, after 2-3 days of treatment, it can be increased to two sprays per nostril, twice a day (standard dosage).
- In case of burning, irritation, frequent sneezing, or tearing, reduce the dosage to one spray per nostril per day; burning generally disappears within a few minutes.
- CILIACELL can cause burning if applied to damaged or sensitized mucosa, for example, in the presence of chronic inflammation or prolonged use of decongestant/vasoconstrictor medications.
- For children, use must be supervised by an adult.
Contraindications:
- Hypersensitivity (allergy) to Cucurbitacins B-D-I-E or other components of the product;
- Untreated viral or bacterial upper respiratory tract infections;
- Acute effusive otitis media without medical supervision; - Use in pregnant women and children under the indicated age or in the presence of conditions requiring specific medical evaluation.
The most frequent effects are:
- Rhinorrhea (evacuation of transparent, yellow-green, or white mucus mixed with fluid), which promotes decongestion and restoration of patency of the upper respiratory tract.
Also, the following may occur:
- Temporary congestion of the nasal mucosa with a feeling of a blocked nose;
- Intensification of symptoms during the first days of treatment (craniofacial pain);
- Burning in the nostrils immediately after administration;
- Sneezing and tearing.
The rarer effects are:
- Irritation of the throat and palate;
- Small streaks of blood in the evacuated mucus (epistaxis), especially in individuals with nasal vascular fragility.
- Slight fever (only for a few hours during the first days of treatment).
Overdosing the product increases the likelihood of the described side effects. If persistent or severe side effects occur, discontinue use and consult a doctor or pharmacist.
All operations must be performed gently: avoid inserting the dispenser tip too deeply into the nostrils and maintain an upright position during application.
After each administration:
- Close the bottle tightly;
- Do not expose to direct light;
- Store away from heat sources.
If intense burning, persistent irritation, frequent sneezing, or tearing is experienced: reduce to one spray per nostril per day or temporarily suspend use - these effects are generally transient.
Specific warnings:
- Overdosing is absolutely not recommended;
- Use in combination with sympathomimetic drugs is not recommended;
- The solution for aerosol therapy must be administered exclusively through a micronized nasal douche. Do not use nebulizers with masks or oral mouthpieces specific for treating the lower respiratory tract;
- Do not use the product after the expiry date;
- CILIACELL solution is not sterile and is not injectable;
- Keep the product out of the reach and sight of children;
- Do not use the product if the bottle is not intact and well sealed.

Storage
Store at a temperature between 10°C and 25°C.
Shelf life when unopened: 24 months.
Shelf life after opening: 2 months.

Format
15 ml bottle.

Code. 008

Product Details

  • Pharmaceutical Form
    Nasal Spray
  • Format
    Bottle
  • Shelf life after opening
    2 months
  • Legislative class
    Medical Device Directive 93/42/EEC
  • Deductible Product
    Yes